Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.
Martin-Yuste V, Brugaletta S, Ferreira-González I, Cola C, Alvarez-Contreras L, de Antonio M, Martí V, García-Picart J, Sabaté M. Martin-Yuste V, et al. EuroIntervention. 2011 Feb;6(7):831-7. doi: 10.4244/EIJV6I7A143. EuroIntervention. 2011. PMID: 21252017
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Martín-Yuste V, Brugaletta S, Sabaté M, Alfonso F, Capote ML, De La Torre JM, Ruíz-Lera M, Sanmiguel D, Cárdenas M, Pujol B, Baz JA, Iñiguez A, Trillo R, González-Béjar O, Casanova J, Sánchez-Gila J, García-Dorado D. Ferreira-González I, et al. Circulation. 2010 Sep 7;122(10):1017-25. doi: 10.1161/CIRCULATIONAHA.110.938290. Epub 2010 Aug 23. Circulation. 2010. PMID: 20733100 Clinical Trial.
Prognostic value of an abnormal ankle-brachial index in patients receiving drug-eluting stents.
Ribera A, Ferreira-González I, Marsal JR, Cascant P, Permanyer-Miralda G, Abdul-Jawad O, Iñigo-Garcia LA, Guarinos-Oltra J, Cequier A, Goicolea-Güemez L, García-Del-Blanco B, Martí G, García-Dorado D. Ribera A, et al. Am J Cardiol. 2011 Nov 1;108(9):1225-31. doi: 10.1016/j.amjcard.2011.06.036. Epub 2011 Aug 25. Am J Cardiol. 2011. PMID: 21872197
Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year.
Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, Martín E, Serra A, Rumoroso JR, Ruiz-Salmerón R, de la Torre JM, Cequier A, Gómez-Hospital JA, Alfonso F, Martín-Yuste V, Sabatè M, García-Dorado D. Ferreira-González I, et al. J Am Coll Cardiol. 2012 Oct 9;60(15):1333-9. doi: 10.1016/j.jacc.2012.04.057. Epub 2012 Sep 19. J Am Coll Cardiol. 2012. PMID: 22999716 Free article.
Impact of revascularization versus medical therapy alone for chronic total occlusion management in older patients.
Flores-Umanzor EJ, Vázquez S, Cepas-Guillen P, Ivey-Miranda J, Caldentey G, Jimenez-Britez G, Regueiro A, Freixa X, Andrea R, Ferreira-González I, Sabaté M, Martin-Yuste V. Flores-Umanzor EJ, et al. Catheter Cardiovasc Interv. 2019 Oct 1;94(4):527-535. doi: 10.1002/ccd.28163. Epub 2019 Mar 3. Catheter Cardiovasc Interv. 2019. PMID: 30828975
Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain).
Ribera A, Ferreira-Gonzalez I, Marsal JR, Oristrell G, Faixedas MT, Rosas A, Tizón-Marcos H, Rojas S, Labata C, Cardenas M, Homs S, Tomas-Querol C, Garcia-Picart J, Gomez-Hospital JA, Pijoan JI, Masotti M, Mauri J, Garcia Dorado D; VESA Study and Codi IAM Investigators. Ribera A, et al. BMJ Open. 2019 Jul 23;9(7):e028114. doi: 10.1136/bmjopen-2018-028114. BMJ Open. 2019. PMID: 31340964 Free PMC article.
Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes.
Flores-Umanzor EJ, Cepas-Guillen PL, Vázquez S, Fernandez-Valledor A, Ivey-Miranda J, Izquierdo M, Caldentey G, Jimenez-Britez G, Regueiro A, Freixa X, Farrero M, Ferreira-González I, Martin-Yuste V, Sabaté M. Flores-Umanzor EJ, et al. Catheter Cardiovasc Interv. 2021 Feb 15;97(3):376-383. doi: 10.1002/ccd.28815. Epub 2020 Feb 25. Catheter Cardiovasc Interv. 2021. PMID: 32096926
273 results